Moderna, Inc. MRNA
NASDAQ · Healthcare · Biotechnology
$195.00
Close on Fri, 20 Nov 2026 · market value $78.9B
No single growth bet
Moderna, Inc. is valued on the income it pays out or on its book, not on one rate of revenue growth, so its price doesn't reduce to a single bet. The three stories below still show what it could be worth.
Both sides
Three stories, three values
Bear
$58
Base
$75
Bull
$84
Today $195
- Bear $58. The margin takes 8 years to reach 16%, what a typical cash-making Health Care company makes. Sales grow 28% a year on average, as analysts expect.
- Base $75. The margin reaches 16%, what a typical cash-making Health Care company makes, in 5 years. Sales grow 28% a year on average, as analysts expect.
- Bull $84. The margin reaches 16% in only 3 years. Sales grow 28% a year on average, as analysts expect.
Stories set by rules from the company’s record.
At a glance
Healthcare · Biotechnology · listed on NASDAQ
- Revenue, FY2025
- $1.9B
- Growth, 3 years a year
- −30%
- Cash margin
- −106%
- Net cash
- $4.5B
- Shares, 3-year change
- −6.5%
- Dividend yield
- 0%
What other healthcare prices are betting on
Figures from company filings and end-of-day market data, as of the close on Fri, 20 Nov 2026; updated every trading day. This page shows what today's price assumes, not whether to buy or sell. Not investment advice.